ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 186 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $6,628,000 | +21.1% | 158,250 | -5.8% | 0.01% | 0.0% |
| Q1 2015 | $5,474,000 | -19.8% | 167,978 | -21.9% | 0.01% | -28.6% |
| Q4 2014 | $6,827,000 | +53.5% | 215,000 | +19.7% | 0.01% | +40.0% |
| Q3 2014 | $4,449,000 | -9.7% | 179,674 | -17.6% | 0.01% | -16.7% |
| Q2 2014 | $4,928,000 | -10.5% | 218,154 | -3.6% | 0.01% | -14.3% |
| Q1 2014 | $5,505,000 | -26.9% | 226,254 | -24.9% | 0.01% | -30.0% |
| Q4 2013 | $7,530,000 | +6.9% | 301,307 | +17.5% | 0.01% | 0.0% |
| Q3 2013 | $7,045,000 | +89.9% | 256,469 | +25.5% | 0.01% | +66.7% |
| Q2 2013 | $3,710,000 | – | 204,375 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |